SPXSY News and Press, Spirax-Sarco Engineering PLC ADR From 10/09/22

Summary Halma's September 2022 trading statement was positive, and M&A activity restarted in October 2022. During times of economic uncertainty, investors can find Halma shares valued without a high premium. We maintain our buy rating, as new investors have an opportunity ...

Spirax-Sarco Engineering plc (SPXSF) Q2 2022 Earnings Conference Call August 11, 2022 4:00 AM ET Company Participants Nicholas Anderson – Group Chief Executive Nimesh Patel – Chief Financial Officer Conference Call Participants Presentatio...

The following slide deck was published by Spirax-Sarco Engineering plc in conjunction with their 2022 Q2 earnings call. For further details see: Spirax-Sarco Engineering plc 2022 Q2 - Results - Earnings Call Presentation

Spirax-Sarco Engineering plc (SPXSF) Q4 2021 Earnings Conference Call March 10, 2022, 04:00 AM ET Company Participants Nicholas Anderson - Group Chief Executive Nimesh Patel - CFO & Executive Director Conference Call Participants Andrew Wilson - JPMorgan Andrew Douglas - Jefferies Robert ...

The following slide deck was published by Spirax-Sarco Engineering plc in conjunction with their 2021 Q4 earnings call. For further details see: Spirax-Sarco Engineering plc 2021 Q4 - Results - Earnings Call Presentation

The following slide deck was published by Spirax-Sarco Engineering plc in conjunction with their 2021 Q2 earnings call. For further details see: Spirax-Sarco Engineering plc 2021 Q2 - Results - Earnings Call Presentation

Spirax-Sarco Engineering plc (SPXSF) 2021 Half Year Results Earnings Conference Call August 11, 2021, 08:00 AM ET Company Participants Nicholas Anderson - Group Chief Executive Nimesh Patel - CFO & Executive Director Conference Call Participants Andrew Wilson - JPMorgan Michael Tyndall - ...

Engineering group Spirax-Sarco continues to perform strongly and has raised its 2021 outlook. With over half a century of dividend raises and the likelihood of continued annual dividend hikes, many income investors like it. But the yield is very small, and valuation hard to justif...

The value of aftermarket business to the John Crane segment of Smiths Group really stood out this quarter, though weak decrementals on a modest revenue decline was a disappointment. The fate of Medical is still uncertain; after years of failed attempts to sell the business, an IPO or ...

Robust biopharma demand for Watson Marlow pumps, tubing, and valves is helping offset weakness across a range of industrial markets and should drive high-single digit long-term growth. Spirax-Sarco's Steam business has unusually close customer relationships, and the company's focus on...